Real-time enrollment status for this arrhythmogenic cardiomyopathy clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT06109181 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Arrhythmogenic Cardiomyopathy |
| Phase | Clinical Trial |
| Target Enrollment | 10 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Lexeo Therapeutics |
| Last Updated on CT.gov | November 12, 2025 (Nov 12, 2025) |
As of March 2, 2026: Clinical trial NCT06109181 is currently active_not_recruiting participants. This clinical trial study for arrhythmogenic cardiomyopathy is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Lexeo Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06109181 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06109181 was last updated Nov 12, 2025 (November 12, 2025). HelloStudys verifies this status automatically.